Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Progressive Gastrointestinal Stromal Tumor × Imatinib Mesylate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Gastrointestinal Stromal Tumors 2 Progressive Gastrointestinal Stromal Tumor 1 Myeloproliferative Disorders 1 Mastocytosis, Systemic 1 Mastocytosis 1 Mast Cell Activation Disorders 1 Leukemia, Myeloid, Chronic-Phase 1 Hematologic Neoplasms 1 Blast Crisis 1

Interventions

Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510354 2020-09-10

Radix

Novartis

Phase 4 Completed

GastrointestinalSarcoma

Progressive Gastrointestinal Stromal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡